Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Oncology

• Publication date

  2000-05-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2000.18.9.1831PMID 10784623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

  1997cited by this paper
• Usefulness of detection of minimal residual disease by ‘hypermetaphase’ fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia

  1997cited by this paper
• Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase‐FISH study

  1996cited by this paper
• Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.

  1995cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.

  1995cited by this paper
• Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid.

  1994cited by this paper
• Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.

  1994cited by this paper
• Graft-versus-leukemia: no longer an epiphenomenon (editorial)

  1993cited by this paper
• Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.

  1993cited by this paper
• Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.

  1993cited by this paper
• Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.

  1993cited by this paper
• Graft-versus-leukemia: no longer an epiphenomenon.

  1993cited by this paper
• Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.

  1993cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia

  1992cited by this paper
• Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemia.

  1990cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia.

  1990cited by this paper
• The Philadelphia chromosome translocation a paradigm for understanding leukemia

  1990cited by this paper
• Treatment of chronic myelogenous leukemia with bone marrow transplantation.

  1990cited by this paper
• Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.

  1990cited by this paper
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

  1990cited by this paper
• Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay.

  1989cited by this paper
• Indications for marrow transplantation in chronic myelogenous leukemia.

  1989cited by this paper
• bcr genes and transcripts.

  1988cited by this paper
• Optimized oligonucleotide probes for DNA fingerprinting

  1988cited by this paper
• Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.

  1987cited by this paper
• Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.

  1986cited by this paper
• Chronic myelogenous leukemia: recent advances.

  1985cited by this paper
• Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia.

  1979cited by this paper

• Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?

  2016cites this paper
• Chimerism monitoring after allogeneic hematopoietic stem cell transplantation using quantitative real-time PCR of biallelic insertion/deletion polymorphisms.

  2014cites this paper
• An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation

  2012cites this paper
• Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation

  2012cites this paper
• Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.

  2010cites this paper
• NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods,

  2010cites this paper
• Novel prognostic factors in chronic myeloid leukemia

  2008cites this paper
• Clinical Significance of Cytogenetics in Myeloproliferative Disorders

  2007cites this paper
• QUANTITATIVE EVALUATION OF CHIMERISM STATUS FOLLOWING HAEMATOPOEITIC STEM CELL TRANSPLANTATION USING A MICROCHIP ELECTROPHORESIS SYSTEM

  2007cites this paper
• Chimerism monitoring following allogeneic hematopoietic stem cell transplantation

  2007cites this paper
• Use of highly sensitive mitochondrial probes to detect microchimerism in xenotransplantation models

  2006cites this paper
• Chronic Myelogenous Leukemia-Progress at the M . D . Anderson Cancer Center over the Past Two Decades and Future Directions : First

  2005cites this paper
• Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.

  2005cites this paper
• How and when should we monitor chimerism after allogeneic stem cell transplantation?

  2005cites this paper
• Molecular Surveillance of Chronic Myeloid Leukemia Patients in the Imatinib Era – Evaluation of Response and Resistance

  2004cites this paper
• Comparison of genetic changes between interphase and metaphase nuclei in monitoring CML and APL treatment using DC-FISH technique

  2004cites this paper
• Short tandem repeat technology has diverse applications: individual identification, phylogenetic reconstruction and chimerism based post haematopoietic stem cell transplantation graft monitoring.

  2004cites this paper
• Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme

  2004cites this paper
• Clinical and practical value of metaphase fluorescent in situ hybridization in follow-up after allogeneic stem cell transplantation in chronic myeloid leukemia.

  2004cites this paper
• Use of ApoB' hyper variable region in studying mixed chimerism and maternal contamination in North Indian populations.

  2004cites this paper
• Stem Cell Transplantation Clinical and practical value of metaphase fluorescence in situ hybridization in follow-up after allogeneic stem cell transplantation in chronic myeloid leukemia

  2004cites this paper
• Aus der Universitäts Klinik für Kinderheilkunde und Jugendmedizin Tübingen Abteilung Kinderheilkunde I mit Poliklinik

  2002cites this paper
• Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases

  2002cites this paper
• Monitoring the course of chronic myelogenous leukemia by fluorescencein Situ hybridization

  2002cites this paper
• Interphase FISH studies of chronic myeloid leukemia.

  2002cites this paper
• Comprehensive comparison of FISH, RT‐PCR, and RQ‐PCR for monitoring the BCR‐ABL gene after hematopoietic stem cell transplantation in CML

  2002cites this paper
• Minimal residual disease in chronic myeloid leukaemia patients.

  2002cites this paper
• Recent publications in hematological oncology.

  2001cites this paper
• FISH monitoring of 100 courses of human leukemias: the cytogenetic viewpoint.

  2001cites this paper
• Near haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe.

  2001cites this paper
• The Differential Cell Count

  2001cites this paper
• Avaliação de doença residual mínima pós-transplante de medula óssea

  2000cites this paper
• Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.

  2000cites this paper